Acute Lymphoblastic Leukemia (ALL) clinical trials
Showing 151–182 of 182 active trials. Describe your situation to see which ones look like a fit.
- Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
- Virtual Reality During Lumbar Punctures in Acute Lymphoblastic Leukemia
- Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
- GM-CSF With Post-Transplant Cyclophosphamide
- A Phase I Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive ALL
- Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL
- Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)
- A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
- CD34+ Transplants for Leukemia and Lymphoma
- Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT
- Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
- Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL
- Weight Gain in Pediatric Leukemia Survivors
- Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT
- The AYA Oncology Self-care Movement
- Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
- Real World Asparaginase Therapy Toxicity
- Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)
- my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Adding Asciminib to Usual Treatment for Adults With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
- Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells
- KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
- Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
- Biology Studies of Hematologic Cancers
- First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
- Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
- A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
- Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- Characterizing Sleep Among Long-term Survivors of Childhood Cancer
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.